During the last decade, global gene-expression analyses have revealed four main distinct subgroups in human breast tumors: luminal A and luminal B (LA and LB), human epidermal growth factor receptor 2-overexpressing (Her2) and basal-like (BLBC) breast cancers [1]–[4]. The gene discussed is ERBB2; the disease is breast carcinoma.